Alan Huang

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Douglas Barry, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alan Huang:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tango Therapeutics, Inc. Chief Scientific Officer Common Stock 167,584 $1,406,264 $8.39 01 Mar 2023 Direct
Tango Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 190,181 01 Mar 2023 Direct

Insider Reports Filed by Alan Huang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TNGX Tango Therapeutics, Inc. 01 Mar 2023 2 $0 4 Chief Scientific Officer 02 Mar 2023, 15:05
TNGX Tango Therapeutics, Inc. 01 Feb 2022 1 $0 4 Chief Scientific Officer 03 Feb 2022, 15:30
TNGX Tango Therapeutics, Inc. 12 Aug 2021 1 $0 4 Chief Scientific Officer 16 Aug 2021, 19:00
TNGX Tango Therapeutics, Inc. 10 Aug 2021 0 $0 3 Chief Scientific Officer 12 Aug 2021, 20:36